X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4431) 4431
Book Chapter (125) 125
Dissertation (8) 8
Publication (7) 7
Magazine Article (6) 6
Book / eBook (5) 5
Newspaper Article (4) 4
Newsletter (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (3190) 3190
life sciences & biomedicine (3139) 3139
humans (3068) 3068
administration, oral (2528) 2528
anticoagulants (2034) 2034
atrial fibrillation (1589) 1589
anticoagulants - administration & dosage (1556) 1556
cardiovascular system & cardiology (1397) 1397
anticoagulants - therapeutic use (1280) 1280
rivaroxaban (1273) 1273
female (1167) 1167
male (1160) 1160
anticoagulants - adverse effects (1149) 1149
aged (1017) 1017
atrial fibrillation - drug therapy (997) 997
stroke (987) 987
warfarin (910) 910
dabigatran (909) 909
cardiac & cardiovascular systems (893) 893
stroke - prevention & control (800) 800
risk factors (786) 786
treatment outcome (779) 779
hematology (757) 757
middle aged (749) 749
thromboembolism (736) 736
hemorrhage - chemically induced (721) 721
apixaban (675) 675
atrial fibrillation - complications (659) 659
peripheral vascular disease (655) 655
direct oral anticoagulants (616) 616
pharmacology & pharmacy (560) 560
aged, 80 and over (544) 544
cardiac arrhythmia (543) 543
bleeding (537) 537
venous thromboembolism (486) 486
medicine & public health (485) 485
patients (478) 478
general & internal medicine (471) 471
stroke - etiology (451) 451
analysis (445) 445
medicine, general & internal (433) 433
care and treatment (428) 428
anticoagulation (420) 420
thrombosis (408) 408
vitamin k - antagonists & inhibitors (406) 406
prevention (394) 394
cardiology (390) 390
abridged index medicus (370) 370
retrospective studies (369) 369
drug therapy (357) 357
pyridones - therapeutic use (350) 350
pyrazoles - therapeutic use (349) 349
warfarin - therapeutic use (348) 348
oral anticoagulants (347) 347
risk assessment (345) 345
pyridones - administration & dosage (338) 338
pyrazoles - administration & dosage (336) 336
blood coagulation - drug effects (333) 333
adult (330) 330
venous thromboembolism - drug therapy (328) 328
factor xa inhibitors (322) 322
fibrillation (322) 322
clinical trials (320) 320
warfarin - administration & dosage (306) 306
rivaroxaban - administration & dosage (301) 301
thrombin (300) 300
rivaroxaban - therapeutic use (293) 293
internal medicine (290) 290
hemorrhage (286) 286
warfarin - adverse effects (278) 278
thromboembolism - prevention & control (277) 277
time factors (268) 268
vitamin k (267) 267
edoxaban (265) 265
anticoagulants - pharmacology (263) 263
venous thromboembolism - prevention & control (263) 263
thiophenes - administration & dosage (262) 262
morpholines - administration & dosage (261) 261
dosage and administration (260) 260
factor xa inhibitors - administration & dosage (260) 260
mortality (259) 259
beta-alanine - analogs & derivatives (256) 256
oral anticoagulation (251) 251
surgery (246) 246
new oral anticoagulants (245) 245
pyridones - adverse effects (240) 240
morpholines - therapeutic use (238) 238
pyrazoles - adverse effects (238) 238
thiophenes - therapeutic use (237) 237
randomized controlled trials as topic (236) 236
cardiovascular (234) 234
rivaroxaban - adverse effects (225) 225
review (224) 224
anticoagulants - pharmacokinetics (222) 222
medical research (222) 222
dose-response relationship, drug (221) 221
pulmonary embolism (220) 220
dabigatran - administration & dosage (218) 218
direct oral anticoagulant (215) 215
cardiovascular diseases (213) 213
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4268) 4268
German (165) 165
French (80) 80
Spanish (65) 65
Russian (55) 55
Japanese (26) 26
Italian (22) 22
Portuguese (18) 18
Hungarian (13) 13
Czech (9) 9
Polish (6) 6
Dutch (4) 4
Norwegian (4) 4
Chinese (3) 3
Turkish (3) 3
Swedish (2) 2
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2010, Volume 363, Issue 26, pp. 2499 - 2510
In this clinical trial, rivaroxaban, an oral factor Xa inhibitor, was effective in the initial and continued treatment of symptomatic venous thromboembolism... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Rivaroxaban | Vitamin K - antagonists & inhibitors | Injections, Subcutaneous | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Acute Disease | Double-Blind Method | Venous Thrombosis - drug therapy | Administration, Oral | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Acenocoumarol - adverse effects | Intention to Treat Analysis | Pulmonary Embolism - drug therapy | Acenocoumarol - therapeutic use | Aged | Hemorrhage - chemically induced | Anticoagulants (Medicine) | Thromboembolism | Drug therapy | Health aspects | Risk factors | Anticoagulants | Bone surgery | Veins & arteries | Index Medicus | Abridged Index Medicus | Venous Thrombosis | Factor Xa | Hemorrhage | Life Sciences | Venous Thromboembolism | Thiophenes | Acenocoumarol | Vitamin K | Warfarin | Enoxaparin | Morpholines | Human health and pathology | Pulmonary Embolism | MEDICIN OCH HÄLSOVETENSKAP | Oral | MEDICAL AND HEALTH SCIENCES | Administration | chemically induced | drug therapy | Subcutaneous | antagonists & inhibitors | Injections | adverse effects | therapeutic use
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2011, Volume 365, Issue 10, pp. 883 - 891
In this trial, 14,264 patients with atrial fibrillation were randomly assigned to receive either rivaroxaban or warfarin... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Thiophenes - administration & dosage | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Aged, 80 and over | Female | Stroke - epidemiology | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Intention to Treat Analysis | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Warfarin | Atrial fibrillation | Patient outcomes | Dosage and administration | Drug therapy | Comparative analysis | Risk factors | Fees & charges | Cardiac arrhythmia | Stroke | Heart attacks | Research & development--R&D | Embolisms | Equity | Equity stake | Hemorrhage | Bleeding | Embolism | Studies | Prevention | Fibrillation | Motivation | Ischemia | Thromboembolism | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Anticoagulants | Morpholines | Life Sciences | Thiophenes | Atrial Fibrillation
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2013, Volume 61, Issue 6, pp. 651 - 658
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2019, Volume 380, Issue 8, pp. 720 - 728
Journal Article